文献速递生殖医学

从青春期前到绝经期人卵巢机械基质体成分的时空变化

Spatiotemporal changes in mechanical matrisome components of the human ovary from prepuberty to menopause.
PubMed 文献 · Hum Reprod · 2020-01-01

该研究定量分析了68例不同年龄女性卵巢皮质中胶原、弹性蛋白、EMILIN-1、原纤维蛋白-1和糖胺聚糖的时空变化,发现这些机械基质体成分的沉积与重塑随年龄和卵泡阶段演变,且雌激素及激素治疗可能对胶原和弹性蛋白有保护作用。

要点

  • 胶原随年龄增加,原纤维蛋白-1和EMILIN-1下降,弹性蛋白在育龄期达峰。
  • 绝经期接受激素治疗者卵巢组织弹性蛋白比例显著高于未接受者(P<0.05)。
  • 青春期前卵泡周围胶原更高、弹性蛋白更低,提示机械应力高、不利激活。

核心结论

  • 参与卵泡激活与发育信号通路的机械基质体成分(胶原、弹性蛋白、EMILIN-1、原纤维蛋白-1和糖胺聚糖)的沉积与重塑随年龄和卵泡阶段演变。

研究设计与样本

  • 研究纳入68例不同年龄患者的卵巢皮质组织:青春期前16例(平均年龄8±2岁)、育龄期21例(平均年龄27±4岁)、接受雌激素类激素替代治疗的绝经期7例(平均年龄58±4岁)、未接受激素替代治疗的绝经期24例(平均年龄61±5岁)。
  • 采用明场图像分析胶原和糖胺聚糖沉积,偏振光显微镜评估胶原纤维特征,多重免疫荧光评估弹性蛋白、原纤维蛋白-1和EMILIN-1的沉积与分布,并结合图像处理和生物信息学分析进行时空定量评估。

主要发现

  • 胶原水平随年龄增加,原纤维蛋白-1和EMILIN-1下降;胶原和弹性蛋白在育龄期女性达到峰值,与青春期前(P<0.01;P=0.262)及接受激素替代治疗(P=0.706;P<0.01)和未接受激素替代治疗(P=0.987;P=0.610)的绝经期受试者相比。
  • 接受激素替代治疗的绝经期女性活检组织中弹性蛋白比例显著高于未接受者(P<0.05)。
  • 成年卵巢糖胺聚糖水平高于青春期前卵巢(P<0.05);糖胺聚糖升高疑似参与阻碍原纤维蛋白-1网络形成(r=-0.2475;P=0.04687),原纤维蛋白-1下降部分解释EMILIN-1减少(r=0.4149;P=0.00059)。
  • 青春期前原始卵泡周围胶原水平更高(P<0.0001)而弹性蛋白含量更低(P<0.0001),初级卵泡周围胶原更高(P<0.0001)而弹性蛋白更低(P<0.001),提示青春期前卵泡处于高机械应力环境,不利于激活而倾向于静息。

临床怎么用

  • 作者认为研究发现为女性生育力和卵巢 rejuvenation 领域提供了可能的ECM层面治疗靶点,如机械刺激、抗纤维化治疗以及预防或逆转弹性ECM降解。
  • 作者认为研究揭示的卵泡阶段和年龄依赖的卵泡特异性ECM组成,可用于设计仿生支架和组织工程模型(如人工卵巢),并强调需将每种分离的卵泡包裹在能复制相应功能性卵泡周围ECM的适当生物材料中,以尊重卵巢组织异质性并保证仿生性。

局限性

  • 研究未考虑接受治疗的绝经期患者组所用激素替代治疗的持续时间和形式。
  • 无法排除研究患者服用的其他非妇科药物对卵巢ECM特性的干扰,因文献中无信息描述每种药物对ECM的影响。
  • 由于ECM按定义是高度异质的蛋白质网架,使用二维组织学可能是一个局限。
  • 固定组织的单一时间点也可能存在局限,因为无法在同一患者中追踪从青春期前到绝经期的卵巢动态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How do elastic matrisome components change during the lifetime of the human ovary? SUMMARY ANSWER: The deposition and remodeling of mechanical matrisome components (collagen, elastin, elastin microfibril interface-located protein 1 (EMILIN-1), fibrillin-1 and glycosaminoglycans (GAGs)) that play key roles in signaling pathways related to follicle activation and development evolve in an age- and follicle stage-related manner. WHAT IS KNOWN ALREADY: The mechanobiology of the human ovary and dynamic reciprocity that exists between ovarian cells and their microenvironment is of high importance. Indeed, while the localization of primordial follicles in the collagen-rich ovarian cortex offers a rigid physical environment that supports follicle architecture and probably plays a role in their survival, ovarian extracellular matrix (ECM) stiffness limits follicle expansion and hence oocyte maturation, maintaining follicles in their quiescent state. As growing follicles migrate to the medulla of the ovary, they encounter a softer, more pliant ECM, allowing expansion and development. Thus, changes in the rigidity of the ovarian ECM have a direct effect on follicle behavior. Evidence supporting a role for the physical environment in follicle activation was provided in clinical practice by ovarian tissue fragmentation, which promoted actin polymerization and disrupted ovarian Hippo signaling, leading to increased expression of downstream growth factors, promotion of follicle growth and generation of mature oocytes. STUDY DESIGN, SIZE, DURATION: We investigated quantitative spatiotemporal changes in collagen, elastin, EMILIN-1, fibrillin-1 and GAGs from prepuberty to menopause, before conducting a closer analysis of the ECM surrounding follicles, from primordial to secondary stages, in both prepubertal and tissue from women of reproductive age. The study included ovarian tissue (cortex) from 68 patients of different ages: prepubertal (n = 16; mean age [±SD]=8 ± 2 years); reproductive (n = 21; mean age [±SD]=27 ± 4 years); menopausal with estrogen-based HRT (n = 7; mean age [±SD]=58 ± 4 years); and menopausal without HRT (n = 24; mean age [±SD]=61 ± 5 years). PARTICIPANTS/MATERIALS, SETTING, METHODS: Quantitative investigations of collagen and GAG deposition in ovarian tissue throughout a woman's lifetime were conducted by analyzing brightfield images. Characteristic features of collagen fiber content were based on polarized light microscopy, since polarized light changes with fiber thickness. To evaluate the deposition and distribution of elastin, fibrillin-1 and EMILIN-1, multiplex immunofluorescence was used on at least three sections from each patient. Image processing and tailored bioinformatic analysis were applied to enable spatiotemporal quantitative evaluation of elastic system component deposition in the human ovary over its lifetime. MAIN RESULTS AND THE ROLE OF CHANCE: While collagen levels increased with age, fibrillin-1 and EMILIN-1 declined. Interestingly, collagen and elastin reached their peak in reproductive-age women compared to prepubertal (P < 0.01; P = 0.262) and menopausal subjects with (P = 0.706; P < 0.01) and without (P = 0.987; P = 0.610) HRT, indicating a positive impact of secreted estrogen and hormone treatment on collagen and elastin preservation. Interestingly, HRT appears to affect elastin presence in ovarian tissue, since a significantly higher (P < 0.05) proportion of elastin was detected in biopsies from menopausal women taking HRT compared to those not. Higher GAG levels were found in adult ovaries compared to prepubertal ovaries (P < 0.05), suggesting changes in tissue ultrastructure and elasticity with age. In this context, elevated GAG values are suspected to participate in hampering formation of the fibrillin-1 network (r = -0.2475; P = 0.04687), which explains its decline over time. This decline partially accounts for the decrease in EMILIN-1 (r = 0.4149; P = 0.00059). Closer examination of the ECM surrounding follicles from the primordial to the secondary stage, both before and after puberty, points to high levels of mechanical stress placed on prepubertal follicles compared to the more compliant ECM around reproductive-age follicles, as suggested by the higher collagen levels and lower elastin content detected mainly around primordial (P < 0.0001; P < 0.0001, respectively) and primary (P < 0.0001; P < 0.001, respectively) follicles. Such a stiff niche is nonpermissive to prepubertal follicle activation and growth, and is more inclined to quiescence. LARGE SCALE DATA: Not applicable. LIMITATIONS, REASONS FOR CAUTION: The duration and form of administered HRT were not considered when studying the menopausal patient group undergoing treatment. Moreover, we cannot exclude interference from other nongynecological medications taken by the study patients on ovarian ECM properties since there is no information in the literature describing the impact of each medication on the ECM. Finally, since the ECM is by definition a very heterogeneous meshwork of proteins, the use of two-dimensional histology could be a limitation. Single time points on fixed tissues could also present limitations, since following ovary dynamics from prepuberty to menopause in the same patient is not feasible. WIDER IMPLICATIONS OF THE FINDINGS: From a biomechanical perspective, our study revealed important changes to ECM properties dictating the mechanical features of ovarian tissue, in line with the existing literature. Our findings pave the way for possible therapeutic targets at the ECM level in the context of female fertility and ovarian rejuvenation, such as mechanical stimulation, antifibrotic treatments, and prevention or reversion of elastic ECM degradation. Our study also sheds light on the follicle-specific ECM composition that is dependent on follicle stage and age. These data will prove very useful in designing biomimetic scaffolds and tissue-engineered models like the artificial ovary. Indeed, they emphasize the importance of encapsulating each type of isolated follicle in an appropriate biomaterial that must replicate the corresponding functional perifollicular ECM and respect ovarian tissue heterogeneity in order to guarantee its biomimicry. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by grants from the Fonds National de la Recherche Scientifique de Belgique (FNRS) (C.A.A. is an FRS-FNRS research associate; grant 5/4/150/5 awarded to M.M.D.) and the Université Catholique de Louvain (PhD grant 'Coopération au développement' awarded to E.O.). None of the authors have any competing interests to declare.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ouni E, Bouzin C, Dolmans MM, et al. Spatiotemporal changes in mechanical matrisome components of the human ovary from prepuberty to menopause. Hum Reprod. 2020. PMID: 32539154. doi:10.1093/humrep/deaa100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。